Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Doctors still prescribe higher-dose menopausal hormone therapy pills

Doctors across the country are still prescribing higher-dose menopausal hormone therapy pills, despite clinical evidence that low doses and skin patches work just as well and carry fewer health risks. That's what researchers at the Stanford University School of Medicine found in a study that will be published online Dec. 2 in Menopause: The Journal of the North American Menopause Society.

3 Dec 2010

Alcohol drinking pattern impacts coronary heart disease

A fascinating study published in the BMJ shows that although the French drink more than the Northern Irish each week, as they drink daily, rather than more on less occasions, the French suffered from considerably less coronary heart disease than the Northern Irish.

3 Dec 2010

Type 2 diabetics who consume alcohol at increased risk for blurry vision

A new study published in the journal Diabetic Medicine reveals that among patients with type 2 diabetes, alcohol consumption was associated with an increased risk of deterioration of visual acuity.

2 Dec 2010

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.

2 Dec 2010

Study reveals role of VSV in killing cancer cells through turning off major survival signal

Researchers from Boston University School of Medicine (BUSM) have identified a mechanism by which specific viruses acting as oncolytic agents can enter and kill cancer cells. This finding, which is currently featured in an online edition of the Journal of Virology, could help lead to the development of more targeted treatments against many types of cancer.

2 Dec 2010

Sleep plays a crucial role in post-infarction remission

The heart and the brain appear to be even more closely connected than previously imagined. The damaging effects of myocardial infarction are apparently not confined to the heart, but also affect the brain.

2 Dec 2010

Sleep HealthCenters enters agreement with U.S. HealthWorks to provide sleep medicine services

Sleep HealthCenters has entered into an agreement with U.S. HealthWorks to provide sleep medicine services as part of their occupational medicine programs.

2 Dec 2010

Genzyme sells genetics business to LabCorp for $925M

Genzyme Corporation today announced that it has completed the sale of Genzyme Genetics to Laboratory Corporation of America Holdings (NYSE: LH) for $925 million in cash.

2 Dec 2010

Researchers show an oncolytic virus switches off cancer cell survival signal

1 Dec 2010

CRN says increased DRI for vitamin D a step in right direction, but still falls short

The Council for Responsible Nutrition (CRN), the dietary supplement industry's leading trade association, today called the National Academy of Sciences Institute of Medicine's (IOM) newly released report on the Dietary Reference Intake (DRI) levels for vitamin D "a modest step in the right direction that fell short of truly capturing the extensive and positive research that has consistently supported the need for people to significantly raise their vitamin D levels."

1 Dec 2010

Study finds link between osteoporosis and cardiovascular disease

Norwegian studies indicate that people with osteoporosis have a greater risk of developing cardiovascular disease, and vice versa. Now researchers believe they have found a biological system that may influence both disease processes.

1 Dec 2010

Fourteen research projects on population health intervention receive $2.8 million

Fourteen research projects on population health intervention research received $2.8 million in funding. The Vice-President of Research at the Canadian Institutes of Health Research (CIHR), Dr. Pierre Chartrand today announced these initiatives during the Population Health Intervention Research Symposium in Toronto.

1 Dec 2010

Vitamin D supplementation may reduce risk of diabetes, heart disease: Research

Researchers from the UC Davis Health System have found that compared with healthy controls, blood levels of vitamin D are significantly reduced in patients in the Sacramento area with metabolic syndrome, a constellation of disease risk factors that affects about one in three U.S. adults and predisposes them to diabetes, heart disease and stroke.

1 Dec 2010

Angptl4 protein deficiency could promote inflammatory response in people who consume high saturated fat

A new report in the December Cell Metabolism identifies a protein without which diets high in saturated fat lead to a massive inflammatory response that can prove fatal. The studies in mice suggest that deficiencies in this protective pathway could promote inflammation in those who regularly consume high levels of saturated fat.

1 Dec 2010

Common sleep complaints predict development of metabolic syndrome: Study

A study in the Dec. 1 issue of the journal SLEEP found that loud snoring and two common insomnia symptoms difficulty falling asleep and unrefreshing sleep each significantly predicted the development of the metabolic syndrome. The study emphasizes the importance of screening for common sleep complaints in routine clinical practice.

1 Dec 2010

Research reveals tricyclic anti-depressants increase risk of CVD

Research that followed nearly 15,000 people in Scotland has shown that a class of older generation anti-depressant is linked to an increased risk of cardiovascular disease (CVD). The study showed that tricyclic anti-depressants were associated with a 35% increased risk of CVD, but that there was no increased risk with the newer anti-depressants such as the selective serotonin reuptake inhibitors (SSRIs).

1 Dec 2010

Aushon, LightArray enter strategic partnership to provide multiplex biomarker products and services in China

Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership with LightArray Biotech Company, Ltd., to provide Aushon's comprehensive suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.

1 Dec 2010

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.

1 Dec 2010

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Inspire Medical Systems, a leading developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) to begin its STAR pivotal clinical trial. The STAR trial (Stimulation Therapy for Apnea Reduction), is a multi-center study that will evaluate both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy in patients with moderate to severe obstructive sleep apnea (OSA).

30 Nov 2010

Are vitamin D and calcium supplements needed?

The IOM raised the recommended dietary allowance of vitamin D from the amount cited in their last report, released 13 years ago. It said that although 600 international units (IUs) of vitamin D or more each day is sufficient to maintain bone health in majority. But those aged 71 and older may need as much as 800 IUs daily, the IOM experts say. However 1997 recommendations advised 400 IUs per day for people aged 51 to 70 and 600 IUs per day for those over 70.

30 Nov 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Doctors still prescribe higher-dose menopausal hormone therapy pills

Alcohol drinking pattern impacts coronary heart disease

Type 2 diabetics who consume alcohol at increased risk for blurry vision

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Study reveals role of VSV in killing cancer cells through turning off major survival signal

Sleep plays a crucial role in post-infarction remission

Sleep HealthCenters enters agreement with U.S. HealthWorks to provide sleep medicine services

Genzyme sells genetics business to LabCorp for $925M

Researchers show an oncolytic virus switches off cancer cell survival signal

CRN says increased DRI for vitamin D a step in right direction, but still falls short

Study finds link between osteoporosis and cardiovascular disease

Fourteen research projects on population health intervention receive $2.8 million

Vitamin D supplementation may reduce risk of diabetes, heart disease: Research

Angptl4 protein deficiency could promote inflammatory response in people who consume high saturated fat

Common sleep complaints predict development of metabolic syndrome: Study

Research reveals tricyclic anti-depressants increase risk of CVD

Aushon, LightArray enter strategic partnership to provide multiplex biomarker products and services in China

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Are vitamin D and calcium supplements needed?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in